Exact Mass: 510.2456

Exact Mass Matches: 510.2456

Found 500 metabolites which its exact mass value is equals to given mass value 510.2456, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulfonyl]piperazin-1-yl)ethyl)quinazoline

4-(Cyclohexyloxy)-2-(1-(4-[(4-methoxybenzene)sulphonyl]piperazin-1-yl)ethyl)quinazoline

C27H34N4O4S (510.2301)

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R),2R,3S*))-

Butanediamide, N4-(5-(acetylamino)-1-((methylamino)carbonyl)pentyl)-N1-hydroxy-2-(((4-hydroxyphenyl)thio)methyl)-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-

C24H38N4O6S (510.2512)

PA(2:0/18:1(12Z)-2OH(9,10))

[(2R)-3-(acetyloxy)-2-{[(9S,10S,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}propoxy]phosphonic acid

C23H43O10P (510.2594)

PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

PA(18:1(12Z)-2OH(9,10)/2:0)

[(2R)-2-(acetyloxy)-3-{[(9R,10R,12Z)-9,10-dihydroxyoctadec-12-enoyl]oxy}propoxy]phosphonic acid

C23H43O10P (510.2594)

PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

4beta,9alpha,20-trihydroxy-13,15-secotiglia-1,6-diene-3,13-dione 20-O-beta-D-glucopyranoside|euphopiloside A|[(3aR,6aS,7S,10R,10aR,10bS)-3,3a,4,6a,7,8,9,10,10a,10b-decahydro-3a,10a-dihydroxy-2,10-dimethyl-3,8-dioxo-7-(propan-2-yl)benzo[e]azulen-5-yl]methyl beta-D-glucopyranoside

4beta,9alpha,20-trihydroxy-13,15-secotiglia-1,6-diene-3,13-dione 20-O-beta-D-glucopyranoside|euphopiloside A|[(3aR,6aS,7S,10R,10aR,10bS)-3,3a,4,6a,7,8,9,10,10a,10b-decahydro-3a,10a-dihydroxy-2,10-dimethyl-3,8-dioxo-7-(propan-2-yl)benzo[e]azulen-5-yl]methyl beta-D-glucopyranoside

C26H38O10 (510.2465)

Manumycin B

C28H34N2O7 (510.2366)

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

5alpha,7beta,10beta,13alpha-tetrahydroxy-2alpha,9alpha,15-triacetoxy-11(15->1)-abeo-taxa-4(20)11-diene|5??,7??,10??,13??-Tetrahydroxy-2??,9??,15-triacetoxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene

C26H38O10 (510.2465)

6,7-dihydrofoliamenthoic acid 1-O-beta-D-glucopyranosyl ester-8-O-beta-D-glucopyranoside

C22H38O13 (510.2312)

10-Debenzoyl-2??-acetoxy-brevifoliol

C26H38O10 (510.2465)

farnesiaside

C26H38O10 (510.2465)

Paniculoside III

C26H38O10 (510.2465)

(4aR,5R,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-6-(hydroxymethyl)-5,8a-dimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|17-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone 18-beta-D-glucopyranosyl ester|caseariaside B

(4aR,5R,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-6-(hydroxymethyl)-5,8a-dimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|17-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone 18-beta-D-glucopyranosyl ester|caseariaside B

C26H38O10 (510.2465)

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

(2alpha)-2-hydroxycleroda-3,13-diene-15,18-dioic acid 15,16-lactone18-beta-D-glucopyranosyl ester|(3R,4aR,5S,6R,8aR)-5-[2-(2,5-dihydro-5-oxofuran-3-yl)ethyl]-3,4,4a,5,6,7,8,8a-octahydro-3-hydroxy-5,6,8a-trimethylnaphthalene-1-carboxylic acid beta-D-glucopyranosyl ester|caseariaside A

C26H38O10 (510.2465)

DEOXYGEDUNOL ACETATE

C30H38O7 (510.2617)

Ile Thr Tyr Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid